Abbott initiates new clinical trial to improve outcomes in patients with advanced heart failure

The first-of-its-kind team-hf study seeks to improve clinical outcomes in patients with worsening heart failure trial establishes new, objective criteria to identify patients most at risk for developing end-stage heart failure and potentially offer life-saving therapeutic options sooner in their disease progression abbott park, ill., oct. 24, 2024 /prnewswire/ -- abbott (nyse: abt) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options.
ABT Ratings Summary
Quant
ABT Quant Ranking
Sector
Industry
Quant Rating
Quant Score